BeOne Medicines
Josh Schraeder currently serves as Executive Director and Head of Project & Portfolio Systems and Reporting at BeiGene since September 2022. Prior experience includes holding the position of Executive Director and Head of Pipeline Systems & Processes at AstraZeneca from 2017 to 2022. Josh's extensive background in the pharmaceutical industry spans over 15 years at Takeda Pharmaceuticals, where roles progressed from Project Manager to Sr. Director in R&D Reporting & Analytics. Earlier in the career, Josh worked as Lead Data Administrator at the College of American Pathologists and as Research Data Coordinator at Abbott. Educational qualifications include a Master’s degree in Health Informatics from the University of Illinois Chicago and a Bachelor’s degree in Health Information Management from Illinois State University.
This person is not in any teams
This person is not in any offices
BeOne Medicines
36 followers
BeOne Medicines is a global oncology company domiciled in Switzerland that is discovering and developing innovative treatments that are more affordable and accessible to cancer patients worldwide. With a portfolio spanning hematology and solid tumors, BeOne is expediting development of its diverse pipeline of novel therapeutics through its internal capabilities and collaborations. With a growing global team of more than 11,000 colleagues spanning six continents, the Company is committed to radically improving access to medicines for far more patients who need them.